ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Medtronic picks Ireland for renal denervation tech manufacturing, McEvoy exits AdvaMed board"
Episode Synopsis
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, October 26, 2023.
Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast.
Abbott this week reported positive data for its MitraClip and TriClip devices. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the most compelling data from the results and what executives think.
A Boston Scientific executive is joining the board of directors at Day Zero Diagnostics. Hear who is taking a board seat and why.
Fresenius Medical Care has a Class I recall of some hemodialysis systems. Find out which devices are affected and what the company is doing to fix the issue.
Ashely McEvoy's departure from Johnson & Johnson means she has to step down from her role as board chair of AdvaMed. Whooley details if the trade organization has chosen a replacement and what AdvaMed CEO Scott Whitaker had to say about her tenure.
Medtronic has selected a location to manufacture its renal denervation technology if it is approved by the FDA. The Fast Five hosts discuss the manufacturing location and the reason behind the hold up of getting the technology to market.
Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast.
Abbott this week reported positive data for its MitraClip and TriClip devices. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the most compelling data from the results and what executives think.
A Boston Scientific executive is joining the board of directors at Day Zero Diagnostics. Hear who is taking a board seat and why.
Fresenius Medical Care has a Class I recall of some hemodialysis systems. Find out which devices are affected and what the company is doing to fix the issue.
Ashely McEvoy's departure from Johnson & Johnson means she has to step down from her role as board chair of AdvaMed. Whooley details if the trade organization has chosen a replacement and what AdvaMed CEO Scott Whitaker had to say about her tenure.
Medtronic has selected a location to manufacture its renal denervation technology if it is approved by the FDA. The Fast Five hosts discuss the manufacturing location and the reason behind the hold up of getting the technology to market.
More episodes of the podcast Fast Five Medtech News Podcast
Edwards reports new outcomes with TAVR; SafeGuard wins breakthrough nod for biodegradable stent
15/03/2024
Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation
14/03/2024
iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program
12/03/2024
Fast Five: FTC may look at Boston Scientific's Axonics buy, Roche unveils new AI-enabled CGM
08/03/2024
Fast Five: Haemonetics buys Attune Medical, Medtronic faces jury trial in spine implant suit
06/03/2024
In God we trust